The Covid-19 pandemic has changed the world in fundamental ways, and the biotechnology sector has been summoned to marshal its broad arsenal of next-generation weapons to beat this disease. As the world undergoes a change, so, too, does BIO. In a fascinating hour of dialogue, history, multimedia content, and conversation, watch the above video to learn how the biotech sector is rising to meet the greatest public health challenge in a century from BIO Chairman Jeremy Levin, new BIO President and CEO Michelle McMurry-Heath, and outgoing CEO and industry champion Jim Greenwood.
- Jeremy Levin, MB BChir, D. Phil, Chairman of the Board of Directors and Chief Executive Officer, Ovid Therapeutics Inc.
- Michelle McMurry-Heath, MD, PhD, President and Chief Executive Officer, Biotechnology Innovation Organization
- James Greenwood, Former President and Chief Executive Officer, Biotechnology Innovation Organization